Publication | Open Access

Efalizumab Therapy for Atopic Dermatitis Causes Marked Increases in Circulating Effector Memory CD4+ T Cells That Express Cutaneous Lymphocyte Antigen

Atopic DermatitisImmune RegulationImmunologySkin AllergyAutoimmunityDermatologyImmunotherapyMedicineEfalizumab TherapyHypersensitivity